Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

HIKMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 89
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

HIKMA

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 89
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

NEXUS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 76
  • 0 comments

FDA approve PROCHLORPERAZINE EDISYLATE

Comment Full text

DR REDDYS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 86
  • 0 comments

FDA approve PALIPERIDONE

Comment Full text

ALEMBIC

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 86
  • 0 comments

FDA approve TADALAFIL

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 93
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 80
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

WATSON LABS

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 89
  • 0 comments

FDA approve CLORAZEPATE DIPOTASSIUM

Comment Full text

BARR

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 80
  • 0 comments

FDA approve GALANTAMINE HYDROBROMIDE

Comment Full text

ZYDUS PHARMS USA INC

  • FDA Approval
  • Feb. 21, 2025, 09:59 UTC
  • 84
  • 0 comments

FDA approve ANASTROZOLE

Comment Full text
  • Previous
  • 233
  • 234
  • 235
  • 236
  • 237
  • Next

Search

News categories

  • Technical Exchange News(12380)
  • Event(6229)
  • SEC News(274050)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158505)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin